(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium

Preferred Label : (4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium;

MeSH note : MEN-16132 is the (4S)-isomer and chloride, hydrochloride salt; structure in first source;

CISMeF synonym : MEN 16132; fasitibant;

MeSH hyponym : MEN16132; MEN-16132;

Is substance : O;

Details

Origin ID

C506838;

UMLS CUI

C1690435;

MeSH indexing information
- receptor, bradykinin b2 [MeSH Descriptor]
MeSH term(s) associated for indexing
- ornithine [MeSH Descriptor]
- sulfonamides [MeSH Descriptor]
Pharmacological action(s)
- Bradykinin B2 Receptor Antagonists [MeSH Descriptor]
Record concept(s)
- (4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium [MeSH concept]
- MEN 16132 [MeSH concept]
- fasitibant [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients